Immune supplementation and immune modulation with intravenous immunoglobulin

J Allergy Clin Immunol. 2005 Oct;116(4):941-4. doi: 10.1016/j.jaci.2005.07.021.

Authors

Bruce D Mazer¹, Salem Al-Tamemi, Joyce W Yu, Qutayba Hamid

Affiliation

¹ Meakins Christie Laboratories, McGill University, Montreal, Canada.

PMID: 16210080
DOI: 10.1016/j.jaci.2005.07.021

No abstract available

MeSH terms

DiGeorge Syndrome / therapy
Guillain-Barre Syndrome / immunology
Guillain-Barre Syndrome / therapy
Humans
Hypersensitivity, Immediate / immunology
Hypersensitivity, Immediate / therapy
Immunoglobulins, Intravenous / administration & dosage
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Deficiency Syndromes / immunology
Immunologic Deficiency Syndromes / pathology
Immunologic Deficiency Syndromes / therapy
Mucocutaneous Lymph Node Syndrome / immunology
Mucocutaneous Lymph Node Syndrome / pathology
Mucocutaneous Lymph Node Syndrome / therapy
Purpura, Thrombocytopenic, Idiopathic / immunology
Purpura, Thrombocytopenic, Idiopathic / pathology
Purpura, Thrombocytopenic, Idiopathic / therapy

Substances

Immunoglobulins, Intravenous